financetom
Business
financetom
/
Business
/
Taiwan Semiconductor Gives Upbeat Revenue Outlook Following Robust Fourth Quarter
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Taiwan Semiconductor Gives Upbeat Revenue Outlook Following Robust Fourth Quarter
Jan 16, 2025 3:52 AM

06:33 AM EST, 01/16/2025 (MT Newswires) -- Taiwan Semiconductor Manufacturing's ( TSM ) US-listed shares rose after the chipmaker recorded sharp gains in its fourth-quarter results and issued an upbeat revenue outlook Thursday for the ongoing period.

The company reported revenue of 868.46 billion New Taiwan dollars ($26.4 billion) for the December quarter, up from NT$625.53 billion a year earlier. The consensus on FactSet was for revenue of NT$867.81 billion. TSMC's New York stock exchange-listed stock increased 3.8% in premarket activity.

"Our business in the fourth quarter was supported by strong demand for our industry-leading (3 nanometer and 5 nanometer) technologies," Chief Financial Officer Wendell Huang said in a statement.

By platform, high-performance computing made up 53% of the fourth-quarter topline and increased 19% from the previous three-month period, according to an earnings presentation. Smartphones contributed 35%, rising 17% on a sequential basis, while automotive and internet of things made up 4% and 5% of the total revenue, respectively.

Earnings of the firm, which supplies chips to major corporations such as Apple (AAPL) and Nvidia (NVDA), came in at NT$72.25 per American depositary receipt unit versus NT$46.03 in the prior-year quarter. Four analysts polled by FactSet expected GAAP EPS of NT$72.54. Gross margin improved 6 percentage points to 59% on a yearly basis.

"Moving into first quarter 2025, we expect our business to be impacted by smartphone seasonality, partially offset by continued growth in (artificial intelligence)-related demand," Huang said.

The company anticipates revenue to be in a range of $25 billion to $25.8 billion for the current quarter, representing a roughly 35% annual increase at the midpoint, Huang said during an earnings call, according to a Capital IQ transcript. The Street is looking for $24.92 billion.

Gross profit margin is pegged at 57% to 59% for the first quarter. The chipmaker also plans to spend between $38 billion and $42 billion in 2025. "About 70% of the capital budget will be allocated for advanced process technologies," Huang said on the call.

TSMC projects its full-year revenue to rise close to the mid-20% range in US dollar terms, Chief Executive C. C. Wei told analysts, while the market estimates $112.45 billion. "Even after more than tripling in 2024, we forecast our revenue from AI accelerator to double in 2025 as the strong surge in AI-related demand continues," according to Wei.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Oct 23, 2024
...
Verona Pharma Insider Sold Shares Worth $2,303,773, According to a Recent SEC Filing
Verona Pharma Insider Sold Shares Worth $2,303,773, According to a Recent SEC Filing
Oct 23, 2024
03:17 AM EDT, 10/23/2024 (MT Newswires) -- Mark W Hahn, Chief Financial Officer, on October 18, 2024, sold 525,768 shares in Verona Pharma ( VRNA ) for $2,303,773. Following the Form 4 filing with the SEC, Hahn has control over a total of 13,813,920 shares of the company, with 13,813,920 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1657312/000110465924110658/xslF345X05/tm2426639-1_4seq1.xml Price: 34.97, Change: +0.10,...
L'Oreal shares fall after its Q3 sales miss forecasts
L'Oreal shares fall after its Q3 sales miss forecasts
Oct 23, 2024
PARIS (Reuters) - L'Oreal's shares slid lower on Wednesday after third quarter sales figures from the French cosmetics giant missed expectations, as low consumer confidence in China sapped demand for beauty products. L'Oreal shares were down around 3 percent in early session trading. Late on Tuesday, L'Oreal posted sales for the three months to the end of September of 10.28...
Verona Pharma Insider Sold Shares Worth $2,253,237, According to a Recent SEC Filing
Verona Pharma Insider Sold Shares Worth $2,253,237, According to a Recent SEC Filing
Oct 23, 2024
03:19 AM EDT, 10/23/2024 (MT Newswires) -- David Zaccardelli, Director, President and Chief Executive Officer, on October 18, 2024, sold 514,152 shares in Verona Pharma ( VRNA ) for $2,253,237. Following the Form 4 filing with the SEC, Zaccardelli has control over a total of 14,736,552 shares of the company, with 14,736,552 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1657312/000110465924110659/xslF345X05/tm2426639-2_4seq1.xml Price: 34.97,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved